about
Pharmacological treatment of spondyloarthritis: exploring the effectiveness of nonsteroidal anti-inflammatory drugs, traditional disease-modifying antirheumatic drugs and biological therapiesBiological therapies for spondyloarthritis.Evolving "Diagnostic" Criteria for Axial Spondyloarthritis in the Context of Anterior Uveitis.TNF Apoptosis Protection Fraction (TAPF) prevents apoptosis induced by TNF, but not by Fas or TRAIL, via NF-κB-induced increase in cFLIP.
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Certolizumab pegol in axial spondyloarthritis.
@en
type
label
Certolizumab pegol in axial spondyloarthritis.
@en
prefLabel
Certolizumab pegol in axial spondyloarthritis.
@en
P2860
P1476
Certolizumab pegol in axial spondyloarthritis.
@en
P2093
In-Ho Song
Martin Rudwaleit
P2860
P304
P356
10.1586/1744666X.2013.858859
P577
2013-12-01T00:00:00Z